ChartSpan Acquires Validic: How This IoT + CCM Powerhouse Unlocks Continuous RPM & Patient-Generated Data for Value-Based Care” (Alternative optimized options:) “ChartSpan Buys Validic: The Ultimate Guide to Seamless RPM Integration for Chronic Care & Shared-Savings Success” “Validic Acquisition by ChartSpan: Why This Deal Closes the Healthcare Data Gap in CCM & Remote Monitoring” “ChartSpan + Validic: How This $XM Deal Transforms Patient-Generated Data into Proactive, EHR-Integrated Care” “Breaking: ChartSpan’s Validic Acquisition Bridges RPM & CCM-Here’s How It Works for Health Systems & Payers” (Best for SEO: Title 1 balances high-volume keywords-“ChartSpan,” “Validic,” “RPM,” “CCM,” “patient-generated data,” “value-based care”-while maintaining clarity and urgency. Adjust based on target audience: providers, payers, or tech investors.)

ChartSpan has finalized the acquisition of Validic, combining the care management leader’s clinical services with Validic’s IoT and health data infrastructure to create a unified platform for continuous remote patient monitoring (RPM) and chronic care management. The move eliminates critical data gaps in value-based care by integrating real-time biometric monitoring with clinical workflows, according to company statements and industry analysts.

With Validic’s Inform API—which normalizes data from over 700 consumer and clinical-grade devices—the combined entity now offers health systems, payers, and life sciences companies a seamless pathway to transform patient-generated health data (PGHD) into actionable clinical insights. The acquisition, backed by financing led by BIP Capital, marks a strategic pivot for ChartSpan beyond provider groups into broader digital health ecosystems.

This development comes as healthcare organizations increasingly face pressure to reduce preventable hospitalizations and improve outcomes under value-based care models. According to the Centers for Medicare & Medicaid Services (CMS), nearly 50% of Medicare spending is tied to patients with five or more chronic conditions—yet traditional care management programs often rely on episodic check-ins that miss critical physiological shifts between visits.

Why This Acquisition Redefines Patient-Generated Health Data

The gap between clinical visits and real-time health monitoring has long been a weak link in value-based care. Traditional Chronic Care Management (CCM) programs, which rely on monthly phone calls from care coordinators, often fail to detect early warning signs of decompensation—such as sudden spikes in blood pressure or glucose levels—until patients present in emergency departments. This fragmentation drives up costs and undermines performance metrics under shared-savings models.

ChartSpan’s acquisition of Validic directly addresses this challenge by merging two critical capabilities:

• Validic’s data infrastructure: A normalized API that ingests and standardizes data from devices like continuous glucose monitors, wearables, and remote blood pressure cuffs, eliminating the need for custom integrations.
• ChartSpan’s clinical expertise: A 24/7 care management workforce trained to act on real-time alerts, reducing preventable hospitalizations by up to 30%, according to internal pilot data cited by ChartSpan.

For health systems operating under Accountable Care Organization (ACO) models, this integration represents a shift from reactive to predictive care. “The traditional approach treats care management and remote monitoring as separate silos,” says Christine Hawkins, CEO of ChartSpan. “By combining Validic’s data layer with our clinical services, we’re helping organizations move from periodic observation to continuous understanding.”

How the Deal Bridges the Data Fragmentation Crisis

The acquisition resolves a long-standing bottleneck in digital health: the lack of interoperability between care management platforms and remote monitoring devices. Historically, health IT procurement teams treated RPM solutions and clinical workflow tools as distinct categories, forcing providers to manage multiple vendors and fragmented data streams. ChartSpan’s integration of Validic’s ecosystem into its existing care orchestration platform creates a unified delivery layer with three key advantages:

1. Universal Biometric Normalization

Validic’s Inform API standardizes data from over 700 devices—ranging from FDA-cleared clinical monitors to consumer wearables—into a single, queryable format. This eliminates the need for health systems to build custom integrations for each device type, reducing implementation timelines by up to 70%, according to Validic’s internal benchmarks.

2. Proactive Clinical Triage

Instead of relying on monthly check-ins, ChartSpan’s care managers can now monitor live biometric alerts in real time. For example, a patient with diabetes whose glucose levels trend upward overnight might trigger an automated alert to a care coordinator, who can then intervene before the patient experiences hypoglycemic or hyperglycemic emergencies. A 2023 study in JAMA Network Open found that such proactive interventions can reduce hospital readmissions by 22% for high-risk patients.

3. Frictionless EHR Integration

The combined platform writes normalized data directly into major electronic health records (EHRs) like Epic and Oracle Health without requiring additional staff training. This seamless workflow integration is critical for adoption, as 68% of providers cite integration challenges as a barrier to adopting new digital health tools.

Expanding Beyond Providers: ChartSpan’s New Market Ambitions

The acquisition represents a strategic expansion for ChartSpan, which has historically focused on ambulatory provider groups. By absorbing Validic’s established product lines—including its API infrastructure, RPM software, and device logistics—the company now positions itself as a multi-sided enterprise platform serving:

• Health systems and ACOs: Structured data pipelines to support population health management and value-based engagement.
• Payers and managed care: Scalable solutions for real-world evidence (RWE) collection and member engagement.
• Life sciences and pharma: Validated platforms for decentralized clinical trials and post-market surveillance.
• Digital health innovators: A developer-friendly sandbox to build next-generation care monitoring applications.

This pivot aligns with broader industry trends. A 2024 report from McKinsey & Company projects that the global remote patient monitoring market will reach $116 billion by 2027, driven by demand for continuous care models. “Some of the most critical health indicators exist outside the clinic walls,” notes Drew Schiller, CEO of Validic. “Joining forces with ChartSpan bridges this gap by combining home-based insights with elite clinical execution.”

What This Means for Patients, Providers, and the Industry

For patients, the integration promises more proactive and personalized care. Instead of waiting for symptoms to worsen between doctor visits, high-risk individuals—such as those managing diabetes, heart failure, or COPD—will benefit from continuous monitoring and earlier interventions. A pilot program conducted by Massachusetts General Hospital using Validic’s platform demonstrated a 40% reduction in emergency department visits for participants with chronic conditions.

Providers, particularly those in value-based care arrangements, stand to gain financially. The CMS ACO program penalizes organizations for preventable hospital readmissions, and the new platform’s real-time monitoring capabilities could help mitigate these costs. “This is about turning data into dollars—literally,” says Dr. Ashish Jha, dean of the Brown University School of Public Health. “When you can predict and prevent crises, you’re not just improving health outcomes; you’re improving the bottom line.”

For the broader digital health ecosystem, the acquisition signals a consolidation trend. As standalone RPM and care management vendors struggle to scale, larger platforms like ChartSpan are acquiring niche players to create end-to-end solutions. This move could accelerate industry standardization around data normalization and interoperability—a critical step toward realizing the ONC’s interoperability goals for seamless health information exchange.

Key Takeaways

• The acquisition combines ChartSpan’s clinical care management with Validic’s IoT and health data infrastructure to create a unified RPM platform.
• Validic’s API normalizes data from over 700 devices, enabling seamless integration with EHRs and care workflows.
• Real-time monitoring reduces preventable hospitalizations by enabling proactive clinical interventions.
• ChartSpan expands its market reach beyond providers to include payers, life sciences, and digital health innovators.
• The deal reflects broader industry trends toward continuous care models and data-driven value-based care.

What Happens Next?

ChartSpan has not yet announced a timeline for product launches or specific customer rollouts, but industry observers expect the integrated platform to be fully operational within 12–18 months. The company will likely prioritize pilots with large health systems and ACOs to demonstrate the platform’s impact on clinical outcomes and cost savings.

For readers interested in tracking developments, ChartSpan’s official updates can be followed on their news page, while Validic’s product roadmap is available here. The next major checkpoint will be ChartSpan’s annual investor day, where the company is expected to provide detailed financial projections for the combined entity.

Have questions about how this acquisition might impact your organization? Share your thoughts in the comments below or reach out to our health policy team for expert analysis.